2
2
2
::::::::
Medical Whistleblower will be interviewing Former Eli Lilly executive, Dr. John Virapen Ph.D. on Monday July 27, 2009 at 9 AM Central Time on BlogTalkRadio. Dr. John Virapen has been working for more than 30 years for the pharmaceutical industry, as manager for Eli-Lilly and Novo Nordisk. He lives now in Germany and has written about his experiences in the pharmaceutical industry in a block buster book, Side Effects: Death, which is available in English, Swedish and German. This information is very especially important in the wake of the recent $1.4 billion settlement from drug maker, Eli Lilly. The drug giant, Eli Lilly, recently plead guilty to promoting its drug Zyprexa for uses not approved by the Food and Drug Administration (FDA). Eli Lilly was found guilty of pushing Zyprexa for extra label uses, withholding research to the public and false advertising. The criminal fine of $515 million is the largest ever in a health care case, and the largest criminal fine for an individual corporation ever imposed in a United States criminal prosecution of any kind. Eli Lilly will also pay up to $800 million in a civil settlement with the federal government and the states.
There have been years of withheld information regarding the adverse side effects of pharmaceuticals promoted by Eli Lilly, including the possible role of Prozac in inducing suicide and homicide. The signs of drug induced violence and suicidality were there since Prozac was first tested in premarketing trials. There were reports of Prozac's adverse side effects of psychotic episodes; reports of completed suicides and attempted suicides, seizures, and even movement disorders.
Oraflex, the American version of Benoxaprofen, was withdrawn from the market in 1982, just one month after gaining FDA approval. A British medical journal found five cases of death due to jaundice in patients taking the drug and the FDA accused Eli Lilly of suppressing unfavorable research findings.
The health risks of Zyprexa included an increased risk for diabetes through Zyprexa's links to obesity and its tendency to raise blood sugar. Zyprexa is Lilly's top-selling drug, with sales of $4.2 billion and over 20 million people worldwide who have taken Zyprexa. Eli Lilly is accused of aggressively marketing Zyprexa and other drugs for extra-label uses by primary care physicians. Long term effects of the use of SSRI's like Zyprexa have not been fully independently studied but these drugs are routinely prescribed for long term use. Preliminary studies point to serious potential adverse side effects of chronic use including movement disorders, cardiac problems, diabetes and Parkinson's disease.
Join us for the radio show on Monday July 27 at 9 AM Central Time (10 AM Eastern Time or 7 AM Pacific Time) call (34.... click on the Medical Whistleblower show on the internet and listen through your computer at http://www.blogtalkradio.com/medicalwhistleblower.
See Dr. John Virapen on YouTube: http://www.youtube.com/watch?v=s-8ItXRMPfA
Read about his story on the web at: click here
